美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

百济神州

255.86

-1.1400-0.44%

盘后：255.860.00000.00%19:37 EDT

成交量：40.22万

成交额：1.03亿

市值：302.96亿

市盈率：-69.09

高：257.61

开：255.22

低：250.00

收：257.00

数据加载中...

总览公司新闻公告

高瓴百济，一别两宽

安进/百济神州CD3/DLL3双抗中国临床研究传捷报，将亮相ASCO

百济神州：公司注册地变更至瑞士

百济神州(06160)：公司英文名称变更为“BeOne Medicines Ltd.”

百济神州百泽安获欧洲药品管理局人用药品委员会积极意见，支持其用于鼻咽癌患者一线治疗

【百济神州宣布塔拉妥单抗中国临床研究取得积极结果】5月26日，据百济神州公众号，该公司今日宣布其与安进公司在中国联合开展的注射用塔拉妥单抗2期临床研究DeLLphi-307已取得积极结果。

百济神州宣布塔拉妥单抗中国临床研究取得积极结果

恒瑞vs百济：人均薪酬&创收比拼

百济神州5月23日成交额为4135.41万美元

恒瑞医药在港上市，创新药出海能否追上百济神州？

《财经》杂志

百济神州：股价涨 2.43% 全年收入指引 49 亿至 53 亿美元

百济神州午前涨超2% 机构看好公司核心产品持续放量

港股异动 | 百济神州(06160)涨近3% 将于2025 ASCO年会上展示产品组合在血液等治疗方面的新数据

百济神州将在2025年ASCO年会上展示开创性研究成果

高瓴资本精准减持破红线，百济神州盈利拐点下的资本退潮谜题

百济神州5月21日成交额为6142.91万美元

港股生物医药板块回调走弱，泰格医药(03347.HK)跌近3%，荣昌生物(09995.HK)跌超2%，百济神州(0616

百济神州(06160)因受限制股份单位获归属发行11.4万股

高瓴正跑步离开百济神州？

百济神州 CLDN6×CD3双抗国内首次启动临床

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/ONC/news?page=2"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ONC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ONC\",,,,,undefined,":{"symbol":"ONC","market":"US","secType":"STK","nameCN":"百济神州","latestPrice":255.86,"timestamp":1749240000000,"preClose":257,"halted":0,"volume":402215,"hourTrading":{"tag":"盘后","latestPrice":255.86,"preClose":255.86,"latestTime":"19:37 EDT","volume":9594,"amount":2454826.56,"timestamp":1749253071067},"delay":0,"floatShares":75624000,"shares":118408800,"eps":-3.70325,"marketStatus":"未开盘","change":-1.14,"latestTime":"06-06 16:00:00 EDT","open":255.22,"high":257.61,"low":250,"amount":102785962.807,"amplitude":0.029611,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.70325,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1749456000000},"marketStatusCode":0,"adr":0,"adrRate":13,"exchange":"NASDAQ","adjPreClose":257,"preHourTrading":{"tag":"盘前","latestPrice":259.99,"preClose":257,"latestTime":"08:01 EDT","volume":221,"amount":56107.18165,"timestamp":1749211287445},"postHourTrading":{"tag":"盘后","latestPrice":255.86,"preClose":255.86,"latestTime":"19:37 EDT","volume":9594,"amount":2454826.56,"timestamp":1749253071067},"volumeRatio":1.558219123925793,"impliedVol":0.4005,"impliedVolPercentile":0.1308},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ONC\",,,,,undefined,":{"symbol":"ONC","floatShares":75624000,"roa":"-3.22%","roe":"-11.44%","lyrEps":-6.124009,"volumeRatio":1.558219123925793,"shares":118408800,"dividePrice":0,"high":257.61,"amplitude":0.029611,"preClose":257,"low":250,"week52Low":141.31,"pbRate":"8.66","psRate":"7.26","week52High":287.88,"institutionHeld":0,"latestPrice":255.86,"eps":-3.70325,"divideRate":0,"volume":402215,"delay":0,"ttmEps":-3.70325,"open":255.22,"prevYearClose":184.71,"prevWeekClose":245.58,"prevMonthClose":245.58,"prevQuarterClose":272.17,"fiveDayClose":245.58,"twentyDayClose":235.94,"sixtyDayClose":249.84},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ONC\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2538413449","title":"高瓴百济，一别两宽","url":"https://stock-news.laohu8.com/highlight/detail?id=2538413449","media":"医曜","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538413449?lang=zh_cn&edition=fundamental","pubTime":"2025-05-28 08:04","pubTimestamp":1748390640,"startTime":"0","endTime":"0","summary":"从2023年首次减持至今，高瓴在百济神州的持股由2022年的11.02%骤降至4.89%。其中，最大的一笔莫过于2020年7月，高瓴作为锚定投资人追加10亿美元，带动百济神州完成20.8亿美元融资，创下全球生物医药史上最大股权融资纪录，这10亿美元也成为全球生物医药史上最大的一笔投资。截至2024年底，高瓴在百济神州的累计投资额已突破13亿美元，持股比例一度高达11.02%。截至2025年一季报，百济神州账上总现金为182.74亿元，不足其一年半的研发投入支出。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250528081619a6ef81b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250528081619a6ef81b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06160","399300","688235","BK0239","ONC","159982"],"gpt_icon":0},{"id":"2538049776","title":"安进/百济神州CD3/DLL3双抗中国临床研究传捷报，将亮相ASCO","url":"https://stock-news.laohu8.com/highlight/detail?id=2538049776","media":"药事纵横","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538049776?lang=zh_cn&edition=fundamental","pubTime":"2025-05-28 06:03","pubTimestamp":1748383406,"startTime":"0","endTime":"0","summary":"5月26日，百济神州与安进公司联合宣布，其靶向DLL3/CD3的双特异性抗体药物塔拉妥单抗在中国开展的2期临床研究DeLLphi-307取得积极结果，拟用于广泛期小细胞肺癌三线及以上治疗，详细数据将在5月30日开幕的ASCO年会上公布。除塔拉妥单抗外，百济神州的PD-1抑制剂替雷利珠单抗、君实生物的特瑞普利单抗均在ES-SCLC一线治疗中取得突破，中位OS超过15个月。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250528061830a6ef69b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250528061830a6ef69b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU1023059063.AUD","BK4581","LU1983299246.USD","LU0889565916.HKD","LU2468319806.SGD","BK4526","BK4533","LU0320765992.SGD","IE00BJJMRZ35.SGD","LU1571399168.USD","IE00B4R5TH58.HKD","AMGN","LU0868494617.USD","BK4599","IE00BFTCPJ56.SGD","BK4534","LU0109394709.USD","LU2112291526.USD","LU2242652126.USD","LU0289739699.SGD","LU2089984988.USD","06160","LU2242646821.SGD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","ONC","BK4566","LU0058720904.USD","SG9999001440.SGD","LU0122379950.USD","IE0002141913.USD","IE0009355771.USD","BK4588","BK4585","LU1057294990.SGD","LU1061106388.HKD"],"gpt_icon":1},{"id":"2538461710","title":"百济神州：公司注册地变更至瑞士","url":"https://stock-news.laohu8.com/highlight/detail?id=2538461710","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538461710?lang=zh_cn&edition=fundamental","pubTime":"2025-05-27 21:26","pubTimestamp":1748352395,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU1969619763.USD","ONC","159982","LU0588546209.SGD","BK1161","688235","AG","BK4139","399300","BK1588","BK1583","LU2328871848.SGD","BK0239","BK1500","06160","BK4210","LU0307460666.USD","BK4526"],"gpt_icon":0},{"id":"2538461382","title":"百济神州(06160)：公司英文名称变更为“BeOne Medicines Ltd.”","url":"https://stock-news.laohu8.com/highlight/detail?id=2538461382","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538461382?lang=zh_cn&edition=fundamental","pubTime":"2025-05-27 20:58","pubTimestamp":1748350727,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百济神州 发布公告，股东于2025年4月28日举行的股东特别大会上通过特别决议案批准采纳拟议瑞士章程后，公司新英文名称于2025年5月27日生效。因此，自2025年5月27日起，公司英文名称由“BeiGene, Ltd.”变更为“BeOne Medicines Ltd.”。公司的中文名称将保持不变。公司英文名称变更后，且在香港联交所确认的前提下，公司于香港联交所股份交易的英文股份简称亦将进行变更。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1298271.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","688235","LU0307460666.USD","LU1969619763.USD","ONC","06160","BK4139","BK0239","BK4526","BK1500","LU2328871848.SGD","BK1161","LU0588546209.SGD","BK1588"],"gpt_icon":0},{"id":"2538505024","title":"百济神州百泽安获欧洲药品管理局人用药品委员会积极意见，支持其用于鼻咽癌患者一线治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2538505024","media":"界面","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538505024?lang=zh_cn&edition=fundamental","pubTime":"2025-05-27 18:24","pubTimestamp":1748341457,"startTime":"0","endTime":"0","summary":"5月27日，百济神州宣布欧洲药品管理局（EMA）人用药品委员会（CHMP）发布积极意见，推荐批准百泽安（替雷利珠单抗）联合吉西他滨和顺铂用于复发性、不适合根治性手术或放疗、或转移性鼻咽癌成年患者的一线治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527182417a6eec685&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527182417a6eec685&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06160","BK4526","ONC","BK4139","688235"],"gpt_icon":0},{"id":"2538144043","title":"【百济神州宣布塔拉妥单抗中国临床研究取得积极结果】5月26日，据百济神州公众号，该公司今日宣布其与安进公司在中国联合开展的注射用塔拉妥单抗2期临床研究DeLLphi-307已取得积极结果。","url":"https://stock-news.laohu8.com/highlight/detail?id=2538144043","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538144043?lang=zh_cn&edition=fundamental","pubTime":"2025-05-26 09:10","pubTimestamp":1748221824,"startTime":"0","endTime":"0","summary":"5月26日，据百济神州公众号，该公司今日宣布其与安进公司在中国联合开展的注射用塔拉妥单抗2期临床研究DeLLphi-307已取得积极结果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/26091050651544.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU0122379950.USD","BK4533","LU1969619763.USD","LU1023059063.AUD","ONC","AMGN","LU0058720904.USD","BK4581","IE00BJT1NW94.SGD","LU0289739699.SGD","LU0320765992.SGD","LU1061106388.HKD","IE00BJJMRZ35.SGD","LU2242652126.USD","BK1161","IE00B4R5TH58.HKD","BK4599","LU2468319806.SGD","SG9999001440.SGD","LU0588546209.SGD","LU2112291526.USD","IE0002141913.USD","BK4526","LU2328871848.SGD","BK4139","LU2242646821.SGD","BK1500","BK4588","LU0889565916.HKD","LU1057294990.SGD","BK0239","BK1583","LU0307460666.USD","LU1983299246.USD","IE00B2B36J28.USD","IE0009355771.USD","BK4585","LU0109394709.USD","BK4534","BK4566","688235","LU1571399168.USD","IE00BFTCPJ56.SGD","06160","LU2089984988.USD","BK1588","LU0868494617.USD"],"gpt_icon":0},{"id":"2538144202","title":"百济神州宣布塔拉妥单抗中国临床研究取得积极结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2538144202","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538144202?lang=zh_cn&edition=fundamental","pubTime":"2025-05-26 09:10","pubTimestamp":1748221816,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["688235","BK0239","LU0889565916.HKD","BK1500","IE00B2B36J28.USD","LU0289739699.SGD","LU0588546209.SGD","IE00BFTCPJ56.SGD","LU2112291526.USD","LU0122379950.USD","LU2328871848.SGD","ONC","LU1061106388.HKD","IE00BJJMRZ35.SGD","LU2242652126.USD","BK4588","BK4534","IE0009355771.USD","BK4526","LU0307460666.USD","BK4566","LU0320765992.SGD","LU1023059063.AUD","LU1057294990.SGD","LU1969619763.USD","LU2468319806.SGD","IE00B4R5TH58.HKD","LU2089984988.USD","BK4139","BK4581","IE0002141913.USD","LU1983299246.USD","LU0868494617.USD","LU0058720904.USD","AMGN","BK4533","BK1583","IE00BJT1NW94.SGD","LU0109394709.USD","06160","SG9999001440.SGD","BK4585","BK1588","LU1571399168.USD","BK4599","LU2242646821.SGD","BK1161"],"gpt_icon":0},{"id":"2538143347","title":"恒瑞vs百济：人均薪酬&创收比拼","url":"https://stock-news.laohu8.com/highlight/detail?id=2538143347","media":"药事纵横","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538143347?lang=zh_cn&edition=fundamental","pubTime":"2025-05-26 00:02","pubTimestamp":1748188942,"startTime":"0","endTime":"0","summary":"恒瑞医药和百济神州是国内创新药赛道两家头部公司，目前市值3400多亿，旗鼓相当。2024年度百济神州的创新药收入高达235.79亿，占总收入的86.65%。恒瑞医药2024年研发费用为82.28亿，研发费用占总营收29%，百济神州研发费用高达141.4亿，研发费用占总营收达51.97%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250526015501a6ec8be9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250526015501a6ec8be9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1969619763.USD","BK0012","BK0188","LU0405327148.USD","LU0405327494.USD","688235","LU1328615791.USD","BK0239","BK0196","LU1064131003.USD","LU2328871848.SGD","LU1064130708.USD","BK0183","LU2148510915.USD","600276","BK0028","ONC","LU2488822045.USD","BK0060","06160"],"gpt_icon":0},{"id":"2537616177","title":"百济神州5月23日成交额为4135.41万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537616177","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537616177?lang=zh_cn&edition=fundamental","pubTime":"2025-05-24 11:11","pubTimestamp":1748056273,"startTime":"0","endTime":"0","summary":"美东时间2025年5月23日，百济神州成交额为4135.41万美元，成交额较昨日减少19.09%，当日成交量为17.15万股。百济神州于2025年5月23日涨1.12%，报241.43美元，该股过去5个交易日涨5.71%，年初至今涨30.71%，过去60日跌13.27%。百济神州有自己的团队进行全球临床试验。截至2023年，百济神州的核心药物是百悦泽，这是一种治疗各种血癌的小分子药物，占百济神州收入的50%以上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250524111120a48a619d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250524111120a48a619d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4526","ONC","BK4139"],"gpt_icon":0},{"id":"2537014149","title":"恒瑞医药在港上市，创新药出海能否追上百济神州？","url":"https://stock-news.laohu8.com/highlight/detail?id=2537014149","media":"《财经》杂志","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537014149?lang=zh_cn&edition=fundamental","pubTime":"2025-05-23 13:48","pubTimestamp":1747979280,"startTime":"0","endTime":"0","summary":"恒瑞医药赴港上市并成为近五年港股最大医药IPO，这是其出海战略的关键一步，但目前公司海外收入仍较小，创新药出海仍有待突破。　　由于超27%的折价发行，恒瑞医药在香港公开发售时受到市场热捧。　　恒瑞医药此次募资，将主要用于研发和海内外新产能建设。相比之下，恒瑞医药虽然手握丰富的创新药管线","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/2025-05-23/doc-inexprke8789000.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/2025-05-23/doc-inexprke8789000.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2488822045.USD","BK0188","06978","BK4139","BK1588","BK1574","BK1161","LU1969619763.USD","LU0307460666.USD","BK1500","LU2328871848.SGD","BK1583","BK0183","LU1328615791.USD","BK0028","LU1064130708.USD","ONC","159992","LU2148510915.USD","BK0060","06160","600276","BK4526","BK0239","LU0405327494.USD","01276","LU0405327148.USD","LU0588546209.SGD","BK0196","LU1064131003.USD","688235","BK0012"],"gpt_icon":0},{"id":"2537019179","title":"百济神州：股价涨 2.43% 全年收入指引 49 亿至 53 亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537019179","media":"和讯网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537019179?lang=zh_cn&edition=fundamental","pubTime":"2025-05-23 12:33","pubTimestamp":1747974825,"startTime":"0","endTime":"0","summary":"【百济神州午前股价上涨 2.43%，现报 147.50 港元，成交额 4.40 亿港元。】5 月 22 日，百济神州宣布将于 2025 年 5 月 30 日至 6 月 3 日在伊利诺伊州芝加哥举行的美国临床肿瘤学会年会上分享 23 篇摘要。主要包括公司产品组合在血液和实体肿瘤治疗方面获得的新数据，两篇摘要被选为进行快速口头报告。申万宏源研报指出，根据公司公告，百济神州 2025 年全年总收入指引仍为 49 亿至 53 亿美元，该行认为公司核心产品持续放量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505231407209762e18b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505231407209762e18b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4526","BK4139","ONC"],"gpt_icon":0},{"id":"2537906140","title":"百济神州午前涨超2% 机构看好公司核心产品持续放量","url":"https://stock-news.laohu8.com/highlight/detail?id=2537906140","media":"新浪网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537906140?lang=zh_cn&edition=fundamental","pubTime":"2025-05-23 11:57","pubTimestamp":1747972655,"startTime":"0","endTime":"0","summary":"百济神州午前股价上涨2.43%，现报147.50港元，成交额4.40亿港元。值得关注的是，申万宏源研报指出，根据公司公告，百济神州2025年全年总收入指引仍为49亿至53亿美元，强劲增长的预期受益于泽布替尼在美国的领先地位以及在欧洲和全球其他重要市场的持续扩张。该行认为，公司是市场上稀缺的同时具有全球化研发和销售能力的创新药公司，核心产品持续放量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505231247119762cf7f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505231247119762cf7f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688235","ONC","BK4526","BK4139"],"gpt_icon":0},{"id":"2537903667","title":"港股异动 | 百济神州(06160)涨近3% 将于2025 ASCO年会上展示产品组合在血液等治疗方面的新数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2537903667","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537903667?lang=zh_cn&edition=fundamental","pubTime":"2025-05-23 11:47","pubTimestamp":1747972055,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，百济神州涨近3%，截至发稿，涨2.5%，报147.6港元，成交额4.25亿港元。消息面上，5月22日，据百济神州官微消息，百济神州宣布将于2025年5月30日至6月3日在伊利诺伊州芝加哥举行的美国临床肿瘤学会年会上分享23篇摘要，主要包括公司产品组合在血液和实体肿瘤治疗方面获得的新数据。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1296770.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1500","06160","LU0307460666.USD","BK1583","LU2328871848.SGD","BK1588","LU0588546209.SGD","BK1161","BK0239","LU1969619763.USD","BK4139","BK4526","ONC","688235"],"gpt_icon":0},{"id":"2537910751","title":"百济神州将在2025年ASCO年会上展示开创性研究成果","url":"https://stock-news.laohu8.com/highlight/detail?id=2537910751","media":"百济神州","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537910751?lang=zh_cn&edition=fundamental","pubTime":"2025-05-22 18:15","pubTimestamp":1747908920,"startTime":"0","endTime":"0","summary":"ASCO是推动癌症治疗进步的强有力平台。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522184546a6e8c298&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522184546a6e8c298&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONC","BK4139","688235","06160","BK4526"],"gpt_icon":0},{"id":"2537998618","title":"高瓴资本精准减持破红线，百济神州盈利拐点下的资本退潮谜题","url":"https://stock-news.laohu8.com/highlight/detail?id=2537998618","media":"华夏时报","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537998618?lang=zh_cn&edition=fundamental","pubTime":"2025-05-22 12:21","pubTimestamp":1747887714,"startTime":"0","endTime":"0","summary":"一场关乎中国创新药“一哥”百济神州（688235/06160/ONC）的资本变动，正引发资本市场热议。近日，百济神州发布公告，股东HHLRFund,L.P.及其联属实体（高瓴资本集团控制的管理公司），在5月9日减持1600万股境外流通股。这一减持直接让其持股比例从6.03%降到了4.89%，不再是公司持股5%以上的大股东。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202505223411783344.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202505223411783344.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1023057109.AUD","BK1142","SG9999001226.SGD","LU0865486749.SGD","LU1251922891.USD","LU0039217434.USD","BK1583","LU1481107354.HKD","LU0345776255.USD","LU0231483743.USD","LU0348805143.USD","89618","LU1328277881.USD","LU2039709279.SGD","LU0348825331.USD","LU0499858602.USD","LU0327786744.USD","LU0320764599.SGD","SG9999002828.SGD","LU0140636845.USD","ONC","LU0315178854.USD","LU2257852520.SGD","LU0791590937.USD","LU0348735423.USD","BK1610","LU0051755006.USD","LU1224444064.USD","LU1282649067.USD","SG9999002562.SGD","LU0431992006.USD","LU0588545730.USD","LU0228367735.SGD","LU0871576103.HKD","BK1249","LU0499858438.USD","LU0456842615.SGD","IE00B3M56506.USD","LU2328871848.SGD","LU0531971595.HKD","LU0048580855.USD","LU1282651121.HKD","LU0128522157.USD","LU0708995583.HKD","LU1770034418.SGD","LU0293314216.USD","LU0594300419.USD","06160"],"gpt_icon":1},{"id":"2537967809","title":"百济神州5月21日成交额为6142.91万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537967809","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537967809?lang=zh_cn&edition=fundamental","pubTime":"2025-05-22 11:14","pubTimestamp":1747883654,"startTime":"0","endTime":"0","summary":"美东时间2025年5月21日，百济神州成交额为6142.91万美元，成交额较昨日增加61.83%，当日成交量为25.92万股。百济神州于2025年5月21日跌0.16%，报236.49美元，该股过去5个交易日涨7.52%，年初至今涨28.03%，过去60日跌8.94%。百济神州有自己的团队进行全球临床试验。截至2023年，百济神州的核心药物是百悦泽，这是一种治疗各种血癌的小分子药物，占百济神州收入的50%以上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522111418a4879828&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522111418a4879828&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONC","BK4526"],"gpt_icon":0},{"id":"2537966106","title":"港股生物医药板块回调走弱，泰格医药(03347.HK)跌近3%，荣昌生物(09995.HK)跌超2%，百济神州(0616","url":"https://stock-news.laohu8.com/highlight/detail?id=2537966106","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537966106?lang=zh_cn&edition=fundamental","pubTime":"2025-05-22 09:36","pubTimestamp":1747877790,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1500","LU1969619763.USD","LU1064131003.USD","ONC","06160","LU0588546209.SGD","LU2488822045.USD","LU1146622755.USD","LU0456842615.SGD","LU0307460666.USD","LU0708995583.HKD","BK0077","LU1997245177.USD","BK4139","LU1997245094.SGD","300347","09995","BK1141","02359","BK1576","603259","LU1046422090.SGD","LU2495084118.USD","07226","HSTECH","LU1064130708.USD","BK0028","LU2242644610.SGD","BK1583","BK1161","03347","LU1820825898.SGD","BK0239","BK1574","LU0320764599.SGD","LU2328871848.SGD","688235","399441","161726","LU2045819591.USD","LU2125910500.SGD","YANG","HSCEI","BK1588","LU1997244956.HKD","BK0216","BK0174","688331","BK4526"],"gpt_icon":0},{"id":"2537950695","title":"百济神州(06160)因受限制股份单位获归属发行11.4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2537950695","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537950695?lang=zh_cn&edition=fundamental","pubTime":"2025-05-22 07:37","pubTimestamp":1747870634,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百济神州(06160)发布公告，于2025年5月21日，发行1.33亿股新股，由公司全资子公司BG NC 2, Ltd为承授人的利益持有，以履行公司根据第三份经修订及重列2016期权及激励计划(不时修订)在根据主板上市规则第17章下股东批准的计划授权限额内，向承授人授予的股权奖励。因根据股权计划授出予公司董事的受限制股份单位获归属而发行11.4万股普通股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1296121.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4139","ONC","LU0307460666.USD","BK1161","LU2328871848.SGD","BK1500","06160","BK1583","BK1588","BK4526","LU1969619763.USD","688235","BK0239","LU0588546209.SGD"],"gpt_icon":0},{"id":"2537604609","title":"高瓴正跑步离开百济神州？","url":"https://stock-news.laohu8.com/highlight/detail?id=2537604609","media":"投资时报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537604609?lang=zh_cn&edition=fundamental","pubTime":"2025-05-21 16:13","pubTimestamp":1747815182,"startTime":"0","endTime":"0","summary":"值得注意的是，高瓴近期已多次减持百济神州。值得一提的是，此次减持还使高瓴从百济神州的第二大股东降为第三大股东。不过眼下高瓴正选择逐步离开百济神州，这或与百济神州一直无法实现有效盈利有关。一季度亏损缩窄公开资料显示，百济神州分别于2016年、2018年和2021年登陆美股、港股和A股上市。5月13日，百济神州发布了2025年一季报，虽然亏损总体同比有所收窄，业绩有所改善，但同样未能由亏转盈。不过券商仍表示了对百济神州的看好。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052116183594fdb13c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052116183594fdb13c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2328871848.SGD","LU0588546209.SGD","BK1588","BK1583","ONC","BK1161","LU1969619763.USD","LU0307460666.USD","688235","BK1500","06160"],"gpt_icon":0},{"id":"2537011826","title":"百济神州 CLDN6×CD3双抗国内首次启动临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2537011826","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537011826?lang=zh_cn&edition=fundamental","pubTime":"2025-05-21 15:35","pubTimestamp":1747812900,"startTime":"0","endTime":"0","summary":"百济神州在国内首次启动CLDN6×CD3双抗BGB-B455的Ⅰ期临床研究，以评估其治疗表达CLDN6的晚期或转移性实体瘤的安全性、耐受性和抗肿瘤活性。CLDN6是恶性肿瘤的潜力靶点，全球有15个靶向CLDN6的在研药进入临床阶段，其中双抗数量最多。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052115584697608169&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052115584697608169&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1500","LU1969619763.USD","BK1161","06160","LU0307460666.USD","BK1583","LU2328871848.SGD","LU0588546209.SGD","BK1588","688235","ONC"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ONC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-07","symbol":"ONC","fiscalQuarterEnding":"2025/03","expectedEps":-0.71,"name":null,"time":"盘前","type":"earning","dateTimestamp":1746590400000,"reportTimeType":"pre","actualEps":1.22},{"market":"US","date":"2025-02-27","symbol":"ONC","fiscalQuarterEnding":"2024/12","expectedEps":-0.88,"name":null,"time":"盘前","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"pre","actualEps":-1.43},{"market":"US","date":"2024-11-12","symbol":"ONC","fiscalQuarterEnding":"2024/09","expectedEps":-0.88,"name":null,"time":"盘前","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-1.15},{"market":"US","date":"2024-08-07","symbol":"ONC","fiscalQuarterEnding":"2024/06","expectedEps":-2.1,"name":null,"time":"盘前","type":"earning","dateTimestamp":1723003200000,"reportTimeType":"pre","actualEps":-1.15},{"market":"US","date":"2024-05-11","symbol":"ONC","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1715400000000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ONC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ONC\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ONC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ONC","date":"2025-06-06","current":-77.688492,"percent":0.003891,"low":-78.0724,"twenty":-43.794804,"median":-38.030583,"eighty":-22.84042,"high":-19.234246,"avg":-35.988763,"sd":13.690738,"marketCap":30482322820},"quantilePoints":[{"date":"2024-05-31","current":-19.860847,"twenty":-20.46703,"median":-20.284421,"eighty":-20.042184,"marketCap":15579384952},{"date":"2024-06-07","current":-20.864085,"twenty":-20.930269,"median":-20.558927,"eighty":-20.042184,"marketCap":16366351618},{"date":"2024-06-14","current":-21.694058,"twenty":-21.409839,"median":-20.844737,"eighty":-20.30869,"marketCap":17017405001},{"date":"2024-06-21","current":-20.966373,"twenty":-21.331475,"median":-20.876952,"eighty":-20.46703,"marketCap":16446589390},{"date":"2024-06-28","current":-19.234246,"twenty":-21.331475,"median":-20.825389,"eighty":-19.981739,"marketCap":15087861974},{"date":"2024-07-05","current":-19.83401,"twenty":-21.208618,"median":-20.693442,"eighty":-19.760805,"marketCap":15558333278},{"date":"2024-07-12","current":-20.525989,"twenty":-21.135228,"median":-20.465877,"eighty":-19.641074,"marketCap":16101139655},{"date":"2024-07-19","current":-20.872652,"twenty":-21.016911,"median":-20.525989,"eighty":-19.707798,"marketCap":16373071895},{"date":"2024-07-26","current":-21.924783,"twenty":-21.374239,"median":-20.660298,"eighty":-19.760805,"marketCap":17198391533},{"date":"2024-08-02","current":-22.081827,"twenty":-21.704901,"median":-20.777003,"eighty":-19.839377,"marketCap":17321581561},{"date":"2024-08-09","current":-37.033118,"twenty":-22.009534,"median":-20.868368,"eighty":-19.874904,"marketCap":19394058972},{"date":"2024-08-16","current":-39.443432,"twenty":-22.36867,"median":-20.966373,"eighty":-19.937065,"marketCap":20656328240},{"date":"2024-08-23","current":-39.274234,"twenty":-33.284244,"median":-21.171036,"eighty":-20.00126,"marketCap":20567720015},{"date":"2024-08-30","current":-38.860864,"twenty":-37.912544,"median":-21.248991,"eighty":-20.190606,"marketCap":20351240040},{"date":"2024-09-06","current":-38.812817,"twenty":-38.506257,"median":-21.456019,"eighty":-20.300725,"marketCap":20326078245},{"date":"2024-09-13","current":-40.29759,"twenty":-38.865563,"median":-21.710093,"eighty":-20.355918,"marketCap":21103646159},{"date":"2024-09-20","current":-41.008162,"twenty":-39.353261,"median":-21.954664,"eighty":-20.405766,"marketCap":21475769498},{"date":"2024-09-27","current":-44.343793,"twenty":-39.883427,"median":-22.072098,"eighty":-20.507104,"marketCap":23222622772},{"date":"2024-10-04","current":-49.961787,"twenty":-40.117185,"median":-22.410559,"eighty":-20.525989,"marketCap":26164738255},{"date":"2024-10-11","current":-47.875901,"twenty":-40.317892,"median":-22.855632,"eighty":-20.558927,"marketCap":25072369873},{"date":"2024-10-18","current":-44.402313,"twenty":-41.008162,"median":-37.033118,"eighty":-20.627155,"marketCap":23253269086},{"date":"2024-10-25","current":-43.1532,"twenty":-43.068033,"median":-37.882149,"eighty":-20.693442,"marketCap":22599114920},{"date":"2024-11-01","current":-41.429716,"twenty":-43.148001,"median":-38.271158,"eighty":-20.724275,"marketCap":21696535276},{"date":"2024-11-08","current":-41.685343,"twenty":-43.068033,"median":-38.746669,"eighty":-20.777003,"marketCap":21830405481},{"date":"2024-11-15","current":-24.188369,"twenty":-42.835701,"median":-38.506257,"eighty":-20.825389,"marketCap":20104967290},{"date":"2024-11-22","current":-24.46985,"twenty":-42.494274,"median":-38.062423,"eighty":-20.864085,"marketCap":20240962418},{"date":"2024-11-29","current":-27.613239,"twenty":-42.262623,"median":-37.45966,"eighty":-20.870939,"marketCap":22851200825},{"date":"2024-12-06","current":-26.519964,"twenty":-42.078114,"median":-35.811244,"eighty":-20.886386,"marketCap":21862847938},{"date":"2024-12-13","current":-23.158686,"twenty":-41.984053,"median":-26.690447,"eighty":-20.951062,"marketCap":19077141333},{"date":"2024-12-20","current":-22.876382,"twenty":-41.961072,"median":-26.519964,"eighty":-21.016911,"marketCap":18791641889},{"date":"2024-12-27","current":-23.581122,"twenty":-41.848457,"median":-25.970587,"eighty":-21.108807,"marketCap":19365505627},{"date":"2025-01-03","current":-23.522344,"twenty":-41.738903,"median":-25.015322,"eighty":-21.169159,"marketCap":19262068568},{"date":"2025-01-10","current":-23.039426,"twenty":-41.667895,"median":-24.95255,"eighty":-21.188412,"marketCap":18831625271},{"date":"2025-01-17","current":-27.361812,"twenty":-41.564427,"median":-24.990614,"eighty":-21.226086,"marketCap":22387798297},{"date":"2025-01-24","current":-28.60727,"twenty":-41.429716,"median":-25.817461,"eighty":-21.248991,"marketCap":23666613889},{"date":"2025-01-31","current":-29.006926,"twenty":-41.129457,"median":-26.292693,"eighty":-21.405551,"marketCap":23976726670},{"date":"2025-02-07","current":-29.003485,"twenty":-41.095232,"median":-26.532547,"eighty":-21.456019,"marketCap":23849552911},{"date":"2025-02-14","current":-29.812673,"twenty":-41.008162,"median":-26.754345,"eighty":-21.694058,"marketCap":24634934161},{"date":"2025-02-21","current":-32.964646,"twenty":-40.974605,"median":-27.361812,"eighty":-21.704901,"marketCap":27250381776},{"date":"2025-02-28","current":-45.085214,"twenty":-41.025576,"median":-28.423545,"eighty":-21.711581,"marketCap":29070314911},{"date":"2025-03-07","current":-41.087466,"twenty":-41.189509,"median":-28.729221,"eighty":-21.882341,"marketCap":26492622821},{"date":"2025-03-14","current":-43.209977,"twenty":-41.608729,"median":-28.790129,"eighty":-21.948688,"marketCap":27861188167},{"date":"2025-03-21","current":-42.024306,"twenty":-41.961072,"median":-29.003485,"eighty":-22.009534,"marketCap":27096684166},{"date":"2025-03-28","current":-44.59433,"twenty":-42.028738,"median":-29.052749,"eighty":-22.054545,"marketCap":28753799426},{"date":"2025-04-04","current":-39.846019,"twenty":-42.270172,"median":-29.231496,"eighty":-22.077935,"marketCap":25692155286},{"date":"2025-04-11","current":-38.484462,"twenty":-42.209323,"median":-29.379987,"eighty":-22.177258,"marketCap":24814242135},{"date":"2025-04-17","current":-38.603,"twenty":-42.109763,"median":-29.75631,"eighty":-22.326782,"marketCap":24890673891},{"date":"2025-04-25","current":-40.929408,"twenty":-42.213935,"median":-30.85745,"eighty":-22.4234,"marketCap":26390709308},{"date":"2025-05-02","current":-42.799955,"twenty":-42.322726,"median":-33.161649,"eighty":-22.493794,"marketCap":27596811853},{"date":"2025-05-09","current":-63.824658,"twenty":-42.611855,"median":-33.528671,"eighty":-22.601969,"marketCap":25042625921},{"date":"2025-05-16","current":-62.94985,"twenty":-42.804476,"median":-34.892623,"eighty":-22.71748,"marketCap":24699380815},{"date":"2025-05-23","current":-72.041871,"twenty":-43.150081,"median":-36.84391,"eighty":-22.787779,"marketCap":28266780880},{"date":"2025-05-30","current":-74.527648,"twenty":-43.429182,"median":-37.087829,"eighty":-22.808465,"marketCap":29242115209},{"date":"2025-06-06","current":-77.688492,"twenty":-43.794804,"median":-38.030583,"eighty":-22.84042,"marketCap":30482322820}],"updateTime":1749410626281}}}